🟢 Humacyte is trading 6.83% up in after-hours trading; catalyst remains uncertain

Humacyte is trading at $0.46, up 6.83%, with no clearly verified company-specific announcement explaining the after-hours move.

• Humacyte’s October 15 update reported a 44% third-quarter increase in hospitals ordering Symvess, from 34 to 49; that earlier news does not establish the cause of this gain.
• Major indexes were lower, so broader market sentiment does not clearly explain the move either.